Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3.

Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC.

EMBO J. 2002 Feb 1;21(3):324-33.

2.

Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.

Ohshima T, Ogawa M, Veeranna, Hirasawa M, Longenecker G, Ishiguro K, Pant HC, Brady RO, Kulkarni AB, Mikoshiba K.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2764-9. Epub 2001 Feb 13.

3.
4.

p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.

Li W, Allen ME, Rui Y, Ku L, Liu G, Bankston AN, Zheng JQ, Feng Y.

J Neurosci. 2016 Nov 2;36(44):11283-11294.

5.

Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling.

Keshvara L, Magdaleno S, Benhayon D, Curran T.

J Neurosci. 2002 Jun 15;22(12):4869-77.

6.

Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Kobayashi H, Saito T, Sato K, Furusawa K, Hosokawa T, Tsutsumi K, Asada A, Kamada S, Ohshima T, Hisanaga S.

J Biol Chem. 2014 Jul 11;289(28):19627-36. doi: 10.1074/jbc.M113.501148. Epub 2014 May 28.

8.

The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.

Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai LH.

Nature. 1998 Sep 10;395(6698):194-8.

PMID:
9744280
9.
10.

p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.

Humbert S, Dhavan R, Tsai L.

J Cell Sci. 2000 Mar;113 ( Pt 6):975-83.

11.

The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.

Hisanaga S, Saito T.

Neurosignals. 2003 Sep-Oct;12(4-5):221-9. Review.

PMID:
14673209
12.

p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH.

J Neurosci. 2001 Sep 1;21(17):6758-71.

13.

The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.

Maccioni RB, Otth C, Concha II, Muñoz JP.

Eur J Biochem. 2001 Mar;268(6):1518-27. Review.

14.

p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.

Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH.

J Biol Chem. 1998 Sep 11;273(37):24057-64.

15.
16.

JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons.

Bruckner SR, Tammariello SP, Kuan CY, Flavell RA, Rakic P, Estus S.

J Neurochem. 2001 Jul;78(2):298-303.

17.

Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology.

Rashid T, Banerjee M, Nikolic M.

J Biol Chem. 2001 Dec 28;276(52):49043-52. Epub 2001 Oct 16.

18.

Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase.

Kwon YT, Gupta A, Zhou Y, Nikolic M, Tsai LH.

Curr Biol. 2000 Apr 6;10(7):363-72.

20.

Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.

Shelton SB, Krishnamurthy P, Johnson GV.

J Neurosci Res. 2004 Apr 1;76(1):110-20.

PMID:
15048935

Supplemental Content

Support Center